Abstract #22: Impact of somatic TP53 mutation type on benefit from bevacizumab in patients with ovarian cancer, a secondary analysis of NRG/GOG-0218

Kristina W. Thiel; Danielle Enserro; Talayeh Ghezelayagh; Marc Radke; Elizabeth Swisher; Krishnansu Tewari; Larry J. Copeland; Heidi Gray; Frederick Ueland; Gottfried Konecny; Premal Thaker; Andrea Wahner-Hendrickson; Heather Lankes; Michael Bookman; Michael Birrer; Barbara Norquist; Kimberly Leslie

doi:10.1016/j.gore.2024.101573

Back

Abstract

Open access

Peer reviewed

Abstract #22: Impact of somatic TP53 mutation type on benefit from bevacizumab in patients with ovarian cancer, a secondary analysis of NRG/GOG-0218

Kristina W. Thiel, Danielle Enserro, Talayeh Ghezelayagh, Marc Radke, Elizabeth Swisher, Krishnansu Tewari, Larry J. Copeland, Heidi Gray, Frederick Ueland, Gottfried Konecny, …

Gynecologic oncology reports, Vol.57, pp.S17-S18

12/2024

DOI: 10.1016/j.gore.2024.101573

Files and links (1)

url

https://doi.org/10.1016/j.gore.2024.101573View

Published (Version of record) Open Access

Details

Title: Subtitle: Abstract #22: Impact of somatic TP53 mutation type on benefit from bevacizumab in patients with ovarian cancer, a secondary analysis of NRG/GOG-0218
Creators: Kristina W. Thiel
Danielle Enserro
Talayeh Ghezelayagh
Marc Radke
Elizabeth Swisher
Krishnansu Tewari
Larry J. Copeland
Heidi Gray
Frederick Ueland
Gottfried Konecny
Premal Thaker
Andrea Wahner-Hendrickson
Heather Lankes
Michael Bookman
Michael Birrer
Barbara Norquist
Kimberly Leslie
Resource Type: Abstract
Publication Details: Gynecologic oncology reports, Vol.57, pp.S17-S18
DOI: 10.1016/j.gore.2024.101573
ISSN: 2352-5789
eISSN: 2352-5789
Language: English
Date published: 12/2024
Academic Unit: Obstetrics and Gynecology
Record Identifier: 9984770791602771

Metrics

4 Record Views